SCHEMBL6602550

SCHEMBL6602550

CCOC(=O)c1ccc(-c2ccccn2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.56
RAB9A P51151 4/20 0.56
SLC11A2 P49281 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
LMNA P02545 2/20 0.54
HTT P42858 1/20 0.54
POLB P06746 1/20 0.53
HKDC1 Q2TB90 1/20 0.53
ALDH1A1 P00352 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
ESR1 P03372 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
ESR2 Q92731 1/20 0.51
CA14 Q9ULX7 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CYP1A2 P05177 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31211646 1.00 NPC1 (0.56) NPC1RAB9ASLC11A2MEN1KMT2A
SCHEMBL2388712 0.87 NPC1 (0.58) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL29978844 0.87 NPC1 (0.58) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL28739865 0.85 MAPT (0.50) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL27771735 0.84 CA12 (0.58) NPC1RAB9ASLC11A2MEN1KMT2A
SCHEMBL1751109 0.84 P4HTM (0.57) NPC1RAB9ASLC11A2MEN1KMT2A
SCHEMBL30772298 0.83 TGFBR1 (0.60) NPC1RAB9AKMT2APOLBALDH1A1
SCHEMBL6259 0.83 TGFBR1 (0.60) NPC1RAB9AKMT2APOLBALDH1A1
SCHEMBL11836546 0.82 CTNNB1 (0.47) NPC1RAB9AMEN1KMT2ALMNA
SCHEMBL15173267 0.81 NPC1 (0.55) NPC1RAB9AMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102344410-A Arylpyridine ortho-position monohalogenated compounds and synthesis method thereof UNIV SHANGHAI 2012-02-08 CN disclosed
CN-1293057-C Ethylenediamine derivatives DAIICHI SEIYAKU CO (JP) 2007-01-03 CN disclosed
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP disclosed
CN-1438993-A Ethylenediamine derivatives DAIICHI SEIYAKU CO (JP) 2003-08-27 CN disclosed
US-6399656-B1 USING A BENZOPYRAN-3-CARBOXAMIDE COMPOUND SMITHKLINE BEECHAM CORPORATION 2002-06-04 US disclosed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP disclosed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed
US-5428160-A Condensation of imidazole derivative with cyano- or halo-substituted benzene derivative containing leaving group esterified with carboxylic or sulfonic acid CIBA-GEIGY CORPORATION (US) 1995-06-27 US disclosed
EP-0165904-B1 SUBSTITUTED BICYCLE COMPOUNDS CIBA-GEIGY AG (CH) 1991-04-10 EP disclosed
US-4889861-A Substituted imidazo[1,5-a]pyridine derivatives and other substituted bicyclic derivatives and their use as aromatase inhibitors CIBA-GEIGY CORP. (US) 1989-12-26 US disclosed
EP-0114573-B1 IMIDAZO(1,5-A)PYRIDINE DERIVATIVES CIBA-GEIGY AG (CH) 1988-04-20 EP disclosed
US-4728645-A THROMBOXANE SYNTHETASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1988-03-01 US disclosed
US-4617307-A Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors CIBA-GEIGY CORPORATION (US) 1986-10-14 US disclosed
US-4588732-A Certain imidazo(1,5-a)pyridine derivatives and their use as thromboxane synthetase inhibitors CIBA-GEIGY CORPORATION (US) 1986-05-13 US disclosed
EP-0165904-A2 Substituted bicycle compounds CIBA-GEIGY AG (CH) 1985-12-27 EP disclosed